SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-001076
Filing Date
2023-01-17
Accepted
2023-01-17 06:20:19
Documents
14
Period of Report
2023-01-14
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vive20230116_8k.htm   iXBRL 8-K 32173
2 EXHIBIT 99.1 ex_464368.htm EX-99.1 10133
  Complete submission text file 0001437749-23-001076.txt   180039

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vive-20230114.xsd EX-101.SCH 3602
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vive-20230114_def.xml EX-101.DEF 11533
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vive-20230114_lab.xml EX-101.LAB 15415
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vive-20230114_pre.xml EX-101.PRE 11689
8 EXTRACTED XBRL INSTANCE DOCUMENT vive20230116_8k_htm.xml XML 2577
Mailing Address 345 INVERNESS DRIVE SOUTH BUILDING B, SUITE 250 ENGLEWOOD CO 80112
Business Address 345 INVERNESS DRIVE SOUTH BUILDING B, SUITE 250 ENGLEWOOD CO 80112 4085301900
VIVEVE MEDICAL, INC. (Filer) CIK: 0000879682 (see all company filings)

IRS No.: 043153858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-11388 | Film No.: 23530141
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
Industrial Applications and Services